Featured Paper of the Month – May 2026
Published in JAMA Network Open by Xiang Xiao and Yihong Yang et al. of the NIDA IRP Magnetic Resonance Imaging and Spectroscopy Section.
Buprenorphine is an FDA-approved medication for opioid addiction, but the brain regions underlying its therapeutic effects are unknown. In this study, we tested whether chronic buprenorphine reduces the time-dependent increase (“incubation”) in heroin seeking during abstinence.










